460 related articles for article (PubMed ID: 15914212)
21. Peroxidase-catalyzed formation of quercetin quinone methide-glutathione adducts.
Awad HM; Boersma MG; Vervoort J; Rietjens IM
Arch Biochem Biophys; 2000 Jun; 378(2):224-33. PubMed ID: 10860540
[TBL] [Abstract][Full Text] [Related]
22. A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes.
Paini A; Punt A; Viton F; Scholz G; Delatour T; Marin-Kuan M; Schilter B; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2010 May; 245(1):57-66. PubMed ID: 20144636
[TBL] [Abstract][Full Text] [Related]
23. Cyproterone acetate: a genotoxic carcinogen?
Kasper P
Pharmacol Toxicol; 2001 May; 88(5):223-31. PubMed ID: 11393581
[TBL] [Abstract][Full Text] [Related]
24. Consequences of quercetin methylation for its covalent glutathione and DNA adduct formation.
van der Woude H; Boersma MG; Alink GM; Vervoort J; Rietjens IM
Chem Biol Interact; 2006 Apr; 160(3):193-203. PubMed ID: 16516181
[TBL] [Abstract][Full Text] [Related]
25. Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1'-hydroxy metabolites.
Chan VS; Caldwell J
Food Chem Toxicol; 1992 Oct; 30(10):831-6. PubMed ID: 1427504
[TBL] [Abstract][Full Text] [Related]
26. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
[TBL] [Abstract][Full Text] [Related]
27. In vitro mutagenesis assays as predictors of chemical carcinogenesis in mammals.
Brusick DJ
Clin Toxicol; 1977; 10(1):79-109. PubMed ID: 404113
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in silico study on consequences of combined exposure to the food-borne alkenylbenzenes estragole and safrole.
Yang S; Kawai T; Wesseling S; Rietjens IMCM
Toxicol In Vitro; 2022 Mar; 79():105290. PubMed ID: 34861381
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
[TBL] [Abstract][Full Text] [Related]
30. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.
Farmer PB; Singh R
Mutat Res; 2008; 659(1-2):68-76. PubMed ID: 18468947
[TBL] [Abstract][Full Text] [Related]
31. Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in drinking water: a review and roadmap for research.
Richardson SD; Plewa MJ; Wagner ED; Schoeny R; Demarini DM
Mutat Res; 2007; 636(1-3):178-242. PubMed ID: 17980649
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
33. [Recent progress in the evaluation of the dangers of chemical carcinogens].
Truhaut R
J Pharm Belg; 1990; 45(2):131-40. PubMed ID: 2192021
[TBL] [Abstract][Full Text] [Related]
34. DNA adducts from alkoxyallylbenzene herb and spice constituents in cultured human (HepG2) cells.
Zhou GD; Moorthy B; Bi J; Donnelly KC; Randerath K
Environ Mol Mutagen; 2007 Dec; 48(9):715-21. PubMed ID: 17948277
[TBL] [Abstract][Full Text] [Related]
35. Safety of quercetin for clinical application (Review).
Okamoto T
Int J Mol Med; 2005 Aug; 16(2):275-8. PubMed ID: 16012761
[TBL] [Abstract][Full Text] [Related]
36. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.
Zahid M; Kohli E; Saeed M; Rogan E; Cavalieri E
Chem Res Toxicol; 2006 Jan; 19(1):164-72. PubMed ID: 16411670
[TBL] [Abstract][Full Text] [Related]
37. Assessment and characterization of DNA adducts produced by alkenylbenzenes in fetal turkey and chicken livers.
Kobets T; Cartus AT; Fuhlbrueck JA; Brengel A; Stegmüller S; Duan JD; Brunnemann KD; Williams GM
Food Chem Toxicol; 2019 Jul; 129():424-433. PubMed ID: 31077736
[TBL] [Abstract][Full Text] [Related]
38. The mutagenicities of safrole, estragole, eugenol, trans-anethole, and some of their known or possible metabolites for Salmonella typhimurium mutants.
Swanson AB; Chambliss DD; Blomquist JC; Miller EC; Miller JA
Mutat Res; 1979 Apr; 60(2):143-53. PubMed ID: 379623
[TBL] [Abstract][Full Text] [Related]
39. Matrix modulation of the bioactivation of estragole by constituents of different alkenylbenzene-containing herbs and spices and physiologically based biokinetic modeling of possible in vivo effects.
Alhusainy W; van den Berg SJ; Paini A; Campana A; Asselman M; Spenkelink A; Punt A; Scholz G; Schilter B; Adams TB; van Bladeren PJ; Rietjens IM
Toxicol Sci; 2012 Sep; 129(1):174-87. PubMed ID: 22649189
[TBL] [Abstract][Full Text] [Related]
40. Comparison of carcinogenic and in vivo genotoxic potency estimates.
Sanner T; Dybing E
Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
